Sarah Hook
#184,747
Most Influential Person Now
New Zealand immunology academic
Sarah Hook's AcademicInfluence.com Rankings
Sarah Hookbiology Degrees
Biology
#15519
World Rank
#19521
Historical Rank
Immunology
#1068
World Rank
#1094
Historical Rank
Download Badge
Biology
Sarah Hook's Degrees
- PhD Immunology University of Auckland
- Masters Microbiology University of New Zealand
Why Is Sarah Hook Influential?
(Suggest an Edit or Addition)According to Wikipedia, Sarah M. Hook is a New Zealand immunology academic, and as of 2019 is a full professor at the University of Otago. Academic career After a 1995 PhD titled 'Cervine Interleukin-4' at the University of Otago, Hook joined the staff, rising to full professor.
Sarah Hook's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Lower Airway Inflammation in Infants with Cystic Fibrosis Detected by Newborn Screening (2005) (229)
- Preparation of phytantriol cubosomes by solvent precursor dilution for the delivery of protein vaccines. (2011) (137)
- Characterisation of bicontinuous cubic liquid crystalline systems of phytantriol and water using cryo field emission scanning electron microscopy (cryo FESEM). (2007) (135)
- Bicontinuous cubic liquid crystals as sustained delivery systems for peptides and proteins (2010) (110)
- Liquid crystalline systems of phytantriol and glyceryl monooleate containing a hydrophilic protein: Characterisation, swelling and release kinetics. (2009) (108)
- Comparative study of liposomes, transfersomes, ethosomes and cubosomes for transcutaneous immunisation: characterisation and in vitro skin penetration (2012) (108)
- Cubosomes containing the adjuvants imiquimod and monophosphoryl lipid A stimulate robust cellular and humoral immune responses. (2013) (92)
- Using different structure types of microemulsions for the preparation of poly(alkylcyanoacrylate) nanoparticles by interfacial polymerization. (2005) (87)
- Bystander suppression of allergic airway inflammation by lung resident memory CD8+ T cells. (2004) (85)
- Stabilising cubosomes with Tween 80 as a step towards targeting lipid nanocarriers to the blood-brain barrier. (2016) (76)
- Mannosylated liposomes as antigen delivery vehicles for targeting to dendritic cells (2006) (76)
- Psychosocial support intervention for HIV-affected families in Haiti: implications for programs and policies for orphans and vulnerable children. (2012) (70)
- CTLA-4 Blockade Enhances the Immune Response Induced by Mycobacterial Infection but Does Not Lead to Increased Protection (1999) (69)
- Recent insights into cutaneous immunization: How to vaccinate via the skin. (2015) (69)
- The role of topical growth factors in chronic wounds. (2007) (69)
- Self-assembled geometric liquid-crystalline nanoparticles imaged in three dimensions: hexosomes are not necessarily flat hexagonal prisms. (2007) (68)
- Microemulsions containing lecithin and sugar-based surfactants: nanoparticle templates for delivery of proteins and peptides. (2008) (67)
- In vivo evaluation of chitosan as an adjuvant in subcutaneous vaccine formulations. (2013) (67)
- Activation of the NLRP3 inflammasome is not a feature of all particulate vaccine adjuvants (2014) (64)
- Oral insulin delivery using nanoparticles based on microemulsions with different structure-types: optimisation and in vivo evaluation. (2009) (62)
- Development and characterisation of modified poloxamer 407 thermoresponsive depot systems containing cubosomes. (2011) (62)
- Efficacy and tolerance of intranasally applied recombinant leukocyte A interferon in normal volunteers. (1983) (55)
- Transcutaneous immunization using microneedles and cubosomes: Mechanistic investigations using Optical Coherence Tomography and Two-Photon Microscopy. (2013) (54)
- Chitosan hydrogels containing liposomes and cubosomes as particulate sustained release vaccine delivery systems (2012) (53)
- Is There an Optimal Formulation and Delivery Strategy for Subunit Vaccines? (2016) (52)
- In vitro and in vivo investigation of thermosensitive chitosan hydrogels containing silica nanoparticles for vaccine delivery. (2010) (51)
- On the preparation, microscopic investigation and application of ISCOMs. (2006) (51)
- In vivo activity of cationic immune stimulating complexes (PLUSCOMs). (2008) (43)
- Modified thermoresponsive Poloxamer 407 and chitosan sol-gels as potential sustained-release vaccine delivery systems. (2015) (39)
- Protein delivery using nanoparticles based on microemulsions with different structure-types. (2008) (38)
- Immunostimulatory colloidal delivery systems for cancer vaccines (2006) (37)
- Effect of incorporation of the adjuvant Quil A on structure and immune stimulatory capacity of liposomes (2004) (36)
- Are phytosomes a superior nanodelivery system for the antioxidant rutin? (2018) (35)
- Characterisation of colloidal drug delivery systems from the naked eye to Cryo-FESEM. (2007) (35)
- Synthetic TRP2 long-peptide and α-galactosylceramide formulated into cationic liposomes elicit CD8+ T-cell responses and prevent tumour progression. (2015) (35)
- Preproenkephalin is a Th2 cytokine but is not required for Th2 differentiation in vitro (1999) (33)
- Cationic cage-like complexes formed by DC-cholesterol, Quil-A, and phospholipid. (2005) (33)
- Rotavirus hospitalisation in New Zealand children under 3 years of age (2006) (33)
- A lipid based multi-compartmental system: Liposomes-in-double emulsion for oral vaccine delivery. (2015) (32)
- Activation of an interleukin‐4 mRNA‐producing population of peripheral blood mononuclear cells after infection with Mycobacterium bovis or vaccination with killed, but not live, BCG (1996) (31)
- Immunogenicity of Liposomes Containing Lipid Core Peptides and the Adjuvant Quil A (2006) (31)
- Comparison of chitosan nanoparticles and chitosan hydrogels for vaccine delivery. (2008) (30)
- Immuno‐stimulating complexes prepared by ethanol injection (2005) (29)
- Novel Injectable Pentablock Copolymer Based Thermoresponsive Hydrogels for Sustained Release Vaccines (2015) (29)
- Quil A-lipid powder formulations releasing ISCOMs and related colloidal structures upon hydration. (2005) (27)
- Comparison of chitosan nanoparticles and chitosan hydrogels for vaccine delivery (2008) (27)
- Advances in Lipid-Based Subunit Vaccine Formulations (2009) (26)
- Spray dried cubosomes with ovalbumin and Quil‐A as a nanoparticulate dry powder vaccine formulation (2018) (26)
- Phosphatidyl choline-based colloidal systems for dermal and transdermal drug delivery (2009) (26)
- Chitosan hydrogel vaccine generates protective CD8 T cell memory against mouse melanoma (2015) (24)
- Poloxamer 407‐chitosan grafted thermoresponsive hydrogels achieve synchronous and sustained release of antigen and adjuvant from single‐shot vaccines (2018) (24)
- Microcontainers for protection of oral vaccines, in vitro and in vivo evaluation. (2019) (23)
- Dynamic Visualization of Dendritic Cell-Antigen Interactions in the Skin Following Transcutaneous Immunization (2014) (23)
- Mechanistic Evaluation of Bioorthogonal Decaging with trans-Cyclooctene: The Effect of Fluorine Substituents on Aryl Azide Reactivity and Decaging from the 1,2,3-Triazoline. (2018) (23)
- Chitosan gel vaccine protects against tumour growth in an intracaecal mouse model of cancer by modulating systemic immune responses (2016) (21)
- First in vivo evaluation of particulate nasal dry powder vaccine formulations containing ovalbumin in mice. (2015) (20)
- Subunit Vaccine Delivery (2015) (20)
- Colocalization of mouse autoimmune diabetes loci Idd21.1 and Idd21.2 with IDDM6 (human) and Iddm3 (rat). (2005) (19)
- Assessment of transcutaneous vaccine delivery by optical coherence tomography (2012) (18)
- The synthesis and immune stimulating action of mannose-capped lysine-based dendrimers (2009) (17)
- Vaccination of Sheep with a Methanogen Protein Provides Insight into Levels of Antibody in Saliva Needed to Target Ruminal Methanogens (2016) (17)
- Th2-dependent airway eosinophilia is regulated by preproenkephalin (2000) (17)
- Chemical Tools for Studying Lipid-Binding Class A G Protein–Coupled Receptors (2017) (16)
- In vivo investigation of twin-screw extruded lipid implants for vaccine delivery. (2014) (16)
- Reasons for use and non-use of the pertussis vaccine during pregnancy: an interview study. (2016) (16)
- Immunostimulatory biodegradable implants containing the adjuvant Quil-A—Part II: In vivo evaluation (2008) (15)
- Critical role of preproenkephalin in experimental autoimmune encephalomyelitis (2006) (14)
- Increased adjuvant activity of minimal CD8 T cell peptides incorporated into lipid‐core‐peptides (2004) (14)
- Cage-like complexes formed by DOTAP, Quil-A and cholesterol. (2007) (14)
- Impact of implant composition of twin-screw extruded lipid implants on the release behavior. (2015) (13)
- Immunostimulatory lipid implants containing Quil-A and DC-cholesterol. (2008) (13)
- Community pharmacy influenza immunisation increases vaccine uptake and gains public approval (2013) (13)
- Lipid-encapsulated oral therapeutic peptide vaccines reduce tumour growth in an orthotopic mouse model of colorectal cancer. (2020) (13)
- Twin‐screw extruded lipid implants containing TRP2 peptide for tumour therapy (2017) (12)
- Characterization and evaluation of stabilized particulate formulations as therapeutic oral vaccines for allergy (2018) (12)
- Mannosylated saponins based on oleanolic and glycyrrhizic acids. Towards synthetic colloidal antigen delivery systems. (2009) (12)
- Absence of preproenkephalin increases the threshold for T cell activation (2003) (12)
- Utilization of Microfluidics for the Preparation of Polymeric Nanoparticles for the Antioxidant Rutin - a comparison with bulk production. (2019) (11)
- Immunostimulatory biodegradable implants containing the adjuvant Quil-A--Part II: In vivo evaluation. (2008) (11)
- Alkyl indole-based cannabinoid type 2 receptor tools: Exploration of linker and fluorophore attachment. (2017) (11)
- Preparation of poly (alkylcyanoacrylate) nanoparticles by polymerization of water-free microemulsions (2006) (11)
- Cubosomes enhance drug permeability across the blood-brain barrier in zebrafish. (2021) (10)
- Analysis of Quil A-phospholipid mixtures using drift spectroscopy. (2007) (10)
- Preliminary evaluation of a thermosensitive chitosan hydrogel for Echinococcus granulosus vaccine delivery. (2017) (10)
- Analysis of Two IL-4 Promoter Polymorphisms in a Cohort of Atopic and Asthmatic Subjects (1999) (10)
- Modeling the Kinetics of the Immune Response (2012) (10)
- Bacteria biohybrid oral vaccines for colorectal cancer treatment reduce tumor growth and increase immune infiltration. (2021) (10)
- Immunostimulatory biodegradable implants containing the adjuvant Quil-A--Part I: Physicochemical characterisation. (2008) (10)
- Improved Antitumor Activity of a Therapeutic Melanoma Vaccine through the Use of the Dual COX-2/5-LO Inhibitor Licofelone (2016) (10)
- Immunostimulatory biodegradable implants containing the adjuvant Quil-A—Part I: Physicochemical characterisation (2008) (9)
- Quantitation of the immunological adjuvants, monophosphoryl lipid A and Quil A in poly (lactic-co-glycolic acid) nanoparticles using high performance liquid chromatography with evaporative light scattering detection. (2015) (9)
- Alkene-Azide 1,3-Dipolar Cycloaddition as a Trigger for Ultrashort Peptide Hydrogel Dissolution. (2018) (8)
- Development of selective, fluorescent cannabinoid type 2 receptor ligands based on a 1,8-naphthyridin-2-(1H)-one-3-carboxamide scaffold. (2018) (7)
- Synthesis, Formulation, and Adjuvanticity of Monodesmosidic Saponins with Olenanolic Acid, Hederagenin and Gypsogenin Aglycones, and some C‐28 Ester Derivatives† (2015) (7)
- Physicochemical and biological characterization of synthetic phosphatidylinositol dimannosides and analogues. (2013) (7)
- Smad2: a candidate gene for the murine autoimmune diabetes locus Idd21.1. (2011) (6)
- Immunogenicity of lipid sustained release implants containing imiquimod, alpha-galactosylceramide, or Quil-A. (2008) (5)
- Tuning activation and self-immolative properties of the bioorthogonal alkene-azide click-and-release strategy. (2020) (5)
- Immune Stimulating Complexes (ISCOMs) and Quil-A Containing Particulate Formulations as Vaccine Delivery Systems (2013) (5)
- On the dilution behaviour of immuno-stimulating complexes (ISCOMs). (2006) (5)
- Liposomal α‐galactosylceramide is taken up by gut‐associated lymphoid tissue and stimulates local and systemic immune responses (2017) (4)
- Distribution of fibroblast growth factor-2 (FGF-2) within model excisional wounds following topical application. (2009) (4)
- Liposomes with cyclodextrin channels and polyethyleneimine (PEI) improves cytoplasmic vaccine delivery and induces anti-cancer immune activity in mice (2020) (4)
- Stability, Kinetic, and Mechanistic Investigation of 1,8-Self-Immolative Cinnamyl Ether Spacers for Controlled Release of Phenols and Generation of Resonance and Inductively Stabilized Methides. (2017) (4)
- Lower airway inflammation in cystic fibrosis infants (2000) (4)
- Development of a Multi-Compartmental Oral Vaccine Delivery System (2016) (3)
- Tetrafluoroaryl azide as an N-terminal capping group for click-to-dissolve diphenylalanine hydrogels (2020) (3)
- Selective quantitation of the incorporation of the immunomodulator α-galactosylceramide in liposomes using LC–MS/MS (2015) (3)
- Synthetic lipopeptides formulated in liposomes: effect on their immune stimulatory capacity in vitro (2006) (2)
- Distribution of fibroblast growth factor‐2 (FGF‐2) within model excisional wounds following topical application (2009) (2)
- Synthesis and formulation of self‐immolative PEG ‐aryl azide block copolymers and click‐to‐release reactivity with trans ‐cyclooctene (2021) (2)
- Vaccine implants: current status and recent advancements. (2020) (1)
- Physical characterization of synthetic phosphatidylinositol dimannosides and analogues in binary systems with phosphatidylcholine. (2014) (1)
- EGFR-targeted prodrug activation using bioorthogonal alkene-azide click-and-release chemistry. (2021) (1)
- Hydrogen Sulfide-Responsive Bicontinuous Nanospheres. (2021) (1)
- Investigations of Vaccine Adjuvant Activity of Liposomes containing Phosphatidylinositol Dimannosides and Analogues (2013) (1)
- Factors influencing formation of ISCOMs and related colloidal particles prepared by the lipid film hydration method (2003) (0)
- Development of lipid based oral vaccine formulations (2016) (0)
- Vaccination and immunotherapy of viral diseases (PP-069) (2010) (0)
- Application of optical coherence tomography for assessment of transcutaneous vaccine delivery (2012) (0)
- Quil A-lipid systems as antigen carriers (2003) (0)
- Pseudo-ternary phase diagrams following hydration or dialysis of Quil A-lipid systems (2003) (0)
- Effect of Resistance Training on Contractile Force Production during Doxorubicin-Treatment: 2640 Board #6 June 1 3 (2018) (0)
- The Effect of Exercise Interventions on Muscle Fiber Type in mdx Mice (2018) (0)
- Microcontainers for protection of oral 1 vaccines , in vitro and in vivo evaluation 2 3 (2018) (0)
- Development of pseudo-ternary phase diagrams of aqueous mixtures of quil A, cholesterol and phospholipid for antigen delivery (2003) (0)
- The Effect of Creatine and Creatinine on Myocellular Injury in Doxorubicin-Treated Skeletal Muscle Myoblasts: 2639 Board #5 June 1 3 (2018) (0)
- One-shot sustained release nanoparticle vaccines (VAC13P.1133) (2015) (0)
- Development of a bioorthogonal fluorescence-based assay for assessing drug uptake and delivery in bacteria (2022) (0)
- Novel Injectable Pentablock Copolymer Based Thermoresponsive Hydrogels for Sustained Release Vaccines (2015) (0)
- Is There an Optimal Formulation and Delivery Strategy for Subunit Vaccines? (2016) (0)
This paper list is powered by the following services:
Other Resources About Sarah Hook
What Schools Are Affiliated With Sarah Hook?
Sarah Hook is affiliated with the following schools:
